If you do a search on our website you will find over 150 articles and slide series about the SGLT-2 inhibitors. The content ranges from research studies to patient cases, to clinician use examples. We believe that all this information makes it easier to decide when to use one of these new medications for your patients. This month, our publisher, Stephen Freed, hit the jackpot when he got an exclusive interview with Dr. Stanley Schwartz, Endocrinologist. Dr. Schwartz has been designated as one of the most prolific prescribers of SGLT-2 inhibitors and he sat down with Steve to share his decision-making process.